Celltrion
068270.KS
#901
Rank
S$34.45 B
Marketcap
S$157.77
Share price
-4.42%
Change (1 day)
12.06%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Half-year Reports

Thumbnail Celltrion
 Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2023-h1

Half-year Report 2023-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2022-h1

Half-year Report 2022-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report